GELS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: December 03, 2025
Report Source: 2025 Annual Report
Gelteq Ltd. Stock Analysis GELS
Gelteq Ltd. operates as a biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 7 full-time employees. The company went IPO on 2024-10-29. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Read More Gelteq Ltd (GELS) Chart
Key Statistics of Gelteq Ltd (GELS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.46Volume
67.10KP/E Ratio (TTM)
-52 Week Range
Market Cap
6.00MAvg. Volume
153.08KDividend Yield
-Financial Metrics & Statements of Gelteq Ltd (GELS)
FAQ's for Gelteq Ltd (GELS)
- According to Musaffa’s Shariah screening methodology, Gelteq Ltd (GELS) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.